Protalix

PLX · NYSE🇺🇸

Overview

Earnings Dividends Seasonality Metrics

NOV

13

Q3 2025

Reported

Reported earnings 3 months ago

Previous year: $8.37M

-0.5%

R&D Expenses

$4.47M

Previous year: $2.99M

+49.4%

SG&A Expenses

$2.93M

Previous year: $2.59M

+13.1%

Cash and Equivalents

$13.6M

Previous year: $27.4M

-50.2%

Total Assets

$82.3M

Previous year: $61.6M

+33.6%

Loading...

Protalix

Unlock previous datapoints

Upgrade

Protalix

Unlock previous datapoints

Upgrade

Protalix Revenue by Segment

Protalix Revenue by Geographic Location

Revenue by Segment

Goods Sales Revenue

CapyFin.com

License & R&D Revenue

CapyFin.com

Revenue by Geographic Location

Pfizer Revenue

CapyFin.com

Fiocruz (Brazil) Revenue

CapyFin.com

Chiesi Revenue

CapyFin.com

Historical Earnings Impact

Analyze how earnings announcements historically affect stock price performance

Avg. Return Before/After Earnings

Loading earnings performance data...

Loading earnings reaction data...

Key Statistics

Market Cap

$188M

P/E Ratio

25.45

Sector

N/A

Industry

N/A

52-Week High

$3.04

52-Week Low

$1.33

Cost of Revenue

$8.32M

R&D Expenses

$4.47M

SG&A Expenses

$2.93M

Financial Income (Net)

$108K

Tax Benefit

$116K

Products

Get in Touch

Resources

Protalix

Protalix

Protalix

Protalix Revenue by Segment

Protalix Revenue by Geographic Location

Revenue by Segment

Goods Sales Revenue

License & R&D Revenue

Revenue by Geographic Location

Pfizer Revenue

Fiocruz (Brazil) Revenue

Chiesi Revenue

Historical Earnings Impact

Avg. Return Before/After Earnings

Key Statistics